A newly recognized medical classification redefines polycystic ovary syndrome as polyendocrine metabolic ovarian syndrome (PMOS), highlighting its broader impact beyond reproductive health. The condition now acknowledges its systemic effects, linking hormonal imbalances to metabolic and endocrine dysfunctions across the body. Experts emphasize that symptoms reach far beyond fertility issues, affecting multiple organ systems. This shift in understanding could reshape diagnosis and treatment approaches for those affected.
Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is a complex condition involving multiple interconnected body systems with symptoms that extend well beyond the ovaries and fertility.
